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Background: To report the diagnostic features and management strategy of a rare case of Weill-Marchesani
syndrome with advanced glaucoma and corneal endothelial dysfunction.
Case presentation: A patient presented with advanced glaucoma with an intraocular pressure of 49 mmHg in the
left eye, and subsequently received trabeculectomy to control the intraocular pressure. Surprisingly, slit lamp
examination through the dilated pupil revealed a dislocated microspherophakic lens almost touching the corneal
endothelium. A microspherophakic lens was confirmed by anterior segment optical coherence tomography.
Weill-Marchesani syndrome was then diagnosed by ocular examinations, and was accompanied by systemic
abnormalities, including brachymorphia and brachydactyly. Corneal endothelial microscopy showed severe corneal
endothelial dysfunction, and lens extraction and intraocular lens implantation were subsequently performed to prevent
further endothelial damage. At the 1-year follow-up visit, the patient had well-controlled intraocular pressure, transparent
cornea, and normal anterior chamber depth, while the intraocular lens remained correctly in place.
Conclusions: Weill-Marchesani syndrome could be diagnosed by microspherophakia, high myopia, secondary
glaucoma, and systemic abnormalities such as brachymorphia and brachydactyly. Removal of the microspherophakia is
recommended to control intraocular pressure and improve vision. Advanced glaucoma in Weill-Marchesani syndrome
should be treated with combined glaucoma surgery and lens extraction.
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Weill-Marchesani syndrome (WMS) is a rare connective
tissue disorder characterized by short stature, brachydac-
tyly, joint stiffness, and lens abnormalities. WMS was
first described by Weill and Marchesani [1,2]. Ocular ab-
normalities include microspherophakia, lens luxation,
high myopia, glaucoma, and corneal changes [3,4]. Sys-
temic abnormalities include short stature, progressive
joint stiffness, brachydactyly, thick skin, mild mental re-
tardation, and cardiac anomalies [5,6]. On an initial exam
by an ophthalmologist, WMS patients are often misdiag-
nosed as high myopia or angle closure glaucoma.
Here we report a rare case with Weill-Marchesani syn-
drome, with advanced glaucoma and corneal endothelial* Correspondence: qiaoz719@hotmail.com
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unless otherwise stated.dysfunction in the left eye. The patient’s right eye had
been blind for over 10 years due to severe glaucoma.
This complex clinical diagnosis in a monocular patient
presented a challenge to determine the best course of
treatment to preserve vision in the remaining eye.
Case presentation
A 30-year-old female presented at our hospital with
blurred vision in her left eye for the past year. She had
previously undergone glaucoma surgeries in both eyes
13 years ago, and her right eye had been blind (no light
perception) for more than 10 years. Her best-corrected vis-
ual acuity (BCVA) was 20/100 in her left eye with −16.0D.
The intraocular pressure (IOP) was 54 mmHg in the
right eye and 49 mmHg in the left eye. On examination,
the anterior chamber of the right eye was quite shallow
and the retina could not be seen because of evident lens
opacity. In the left eye, the anterior chamber was extremelyis is an Open Access article distributed under the terms of the Creative
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pale and the cup-to-disc (C/D) ratio was 0.99 in the left
eye. Visual field testing with the Humphrey field vision
test demonstrated an extremely narrow tubular field of
vision in the left eye. Given the patient’s history of glau-
coma surgery, high IOP, small cornea, and extremely nar-
row anterior chamber, malignant glaucoma was highly
suspected. The high IOP of 49 mmHg and advanced
visual field loss warranted aggressive therapy. A trabe-
culectomy was performed in the left eye and atropine
ointment was administered to dilate the pupil. On post-
operative day 1, the IOP of the left eye was 20 mmHg.
Surprisingly, the equator of the lens could be visualized
through the dilated pupil. The lens appeared small and
spherical with a slight upward dislocation (Figure 1A).
The suspensory ligaments could be seen clearly under
high magnification (Figure 1B). Anterior segment op-
tical coherence tomography (OCT) was performed and
revealed a microspherophakic lens with horizontal diam-
eter of approximately 9 mm and anteroposterior diam-
eter of approximately 8 mm (Figure 1C). A general
physical examination of the patient demonstrated shortFigure 1 Ocular and systemic abnormalities of a case of
Weill-Marchesani syndrome. (A) The lens appeared small and
spherical with a slight upward dislocation. (B) The suspensory
ligaments are clearly seen under high magnification. (C) The lens was
microspherophakic (arrows), with a diameter of approximately 9 mm
and an anteroposterior diameter of approximately 8 mm when
observed using anterior segment optical coherence tomography (OCT).
(D, E) The patient presented with short fingers and toes. (F) The
patient presented with a transparent cornea and normal depth of
the anterior chamber after phacoemulsification and intraocular
lens implantation.stature (145 cm) and brachydactyly (Figure 1D,E), thus
the diagnosis was modified to WMS. The patient re-
ported no family history of this condition, or of consan-
guineous marriage, so this likely represented a sporadic
case of WMS. Corneal endothelium microscopy of the
left eye showed significantly reduced endothelial cells
with a cell count of 576 cells/mm2 suggesting the cor-
neal endothelium was severely damaged. To prevent
further corneal endothelial damage and decompensation,
phacoemulsification and intraocular lens implantation
were performed in the left eye. A +24D intraocular lens
was successfully implanted into the lens capsule. At the
1-year follow-up visit, the patient had well-controlled in-
traocular pressure, transparent cornea, and normal anter-
ior chamber depth, while the intraocular lens remained
correctly in place (Figure 1F).
Conclusions
Weill-Marchesani syndrome, also known as microsphero-
phakia-brachydactyly syndrome, is a rare and usually her-
itable connective tissue disorder characterized by short
stature, brachydactyly, lens microspherophakia, lens lux-
ation, high myopia, and glaucoma. Most patients carry an
autosomal dominant or autosomal recessive gene muta-
tion, and most have a family history of this condition.
Faivre et al. reported that autosomal recessive and auto-
somal dominant inheritance accounted for 45% and 39%
of WMA cases, respectively, and the remaining cases
were sporadic [7]. Patients with WMS have a high inci-
dence of secondary glaucoma, and recurrent glaucoma
attacks will lead to angle adhesion and trabecular mesh-
work damage, resulting in chronically increased IOP, and
eventually in permanent damage to the optic nerve. The
patient in this case report had a history of glaucoma for
more than 13 years, and her right eye had no light per-
ception for over 10 years. Her left eye had severe optic
neuropathy, and an extremely narrow tubular field of vi-
sion resulted from chronically elevated intraocular pres-
sure. As she was a monocular patient, we tried to lower
the IOP immediately to prevent further damage to the
optic nerve and preserve her remaining vision. The pa-
tient had more risk of complications for a lens extraction
procedure under such high IOP, including the extinction
phenomenon or an expulsive choroidal hemorrhage. Be-
cause of these possible complications, we performed tra-
beculectomy the day after her admission, to lower the
IOP as soon as possible. Atropine was applied at the
same time to resolve the pupillary block. After the sur-
gery, we incidentally discovered the microspherophakia.
At this point, the diagnosis was modified to Weill-
Marchesani syndrome.
The microspherophakia provided a good explanation
for the high myopia without myopic retinopathy, narrow
anterior chamber, and glaucoma. An abnormal increase
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Therefore, patients with high myopia without axial ex-
tension of the eye, or pathological myopic changes in
the retina, should be further examined for microsphero-
phakia. The increased lens thickness results in a narrow
anterior chamber and angles, and the lens moves for-
ward due to zonular relaxation, which leads to pupillary
block and elevated IOP. This patient’s IOP was well con-
trolled after trabeculectomy, but due to zonular relax-
ation, the lens moved forward and almost came into
contact with the corneal endothelium. It was therefore
necessary to remove the microspherophakic lens in
order to avoid corneal endothelial decompensation. Be-
cause this was a monocular patient, the lens extraction
needed to be performed with extreme caution. Given the
patient’s corneal endothelium was already severely im-
paired, it was risky to perform phacoemulsification from
a limbal incision, because this could have led to corneal
decompensation. However, the retina examination dem-
onstrated a C/D ratio of 0.99 and extremely narrow
tubular field of vision, therefore it was more risky to per-
form anterior vitrectomy and lensectomy from a ciliary
pars plana incision. This approach could lead to an ex-
tinction phenomenon, choroidal detachment, and retinal
detachment. After a careful evaluation of all surgical op-
tions, we performed phacoemulsification and intraocular
lens implantation, and an IOL was successfully implanted
into the capsule. This patient has been followed up, and
currently her eye is in stable condition. At a 1-year follow-
up visit, the vision of her left eye was 20/100, the IOP was
10–12 mmHg, and the cornea remained clear.
This case of WMS demonstrated microspherophakia
and lens luxation, high myopia, glaucoma, and systemic
abnormalities, including short stature and brachydactyly.
Recently, additional features of WMS were reported in
the literature. Razeghinejad et al. analyzed the corneal
thickness in six cases of WMS, and found that the aver-
age corneal thickness was 631.5 ± 25.9 μm in WMS pa-
tients, while it was 535.8 ± 25.9 μm in normal subjects
[4]. By confocal examination, Roszkowska et al. revealed
that this increase in corneal thickness was associated
with the activation of keratocytes in the anterior stroma,
suggesting that corneal thickness increase was a newly
described disease feature of WMS [8]. Therefore, when
measuring and assessing the IOP, the influence of cor-
neal thickness on the IOP measurement should be taken
into consideration.
WMS is a rare disease with a variety of clinical mani-
festations, and at present there is no universally accepted
treatment modality. Removal of the microspherophakic
lens was recommended to control intraocular pressure
and increase vision [9-11]. Whether the glaucoma sur-
gery is needed depends on the glaucoma course. If the
patient has early glaucoma and most of the anteriorchamber angle remains open, a simple removal of micro-
spherophakia could be performed. When the patient has
advanced glaucoma with angle closure, a combined glau-
coma surgery with lens extraction should be considered.
Senthil et al. recently reported 159 eyes of 80 patients with
microspherophakia, among which glaucoma was diag-
nosed in 81 eyes (51%) [11]. Of the 48 eyes that required
surgical intervention, 24 eyes underwent trabeculectomy.
Complete success probability of trabeculectomy was 86%
at 6 months, 77% at 1 year, was maintained for 7 years,
and was reduced to 61% at 8 years. At the last follow-up,
30% of the eyes were blind due to glaucoma. Therefore, a
timely diagnosis and treatment in patients with WMS is
of vital importance to maintain and rescue their visual
function.
In conclusion, Weill-Marchesani syndrome is a rare
disease characterized by microspherophakia, high my-
opia, secondary glaucoma, and systemic abnormalities
such as brachymorphia and brachydactyly. Clinicians
should be aware of patients presenting with high myopia
who have narrow anterior chamber but no myopic retin-
opathy. Removal of the microspherophakia is recom-
mended to control intraocular pressure and preserve
vision. Advanced glaucoma in WMS should be treated
with combined glaucoma surgery with lens extraction.
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